Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Anzemet Tablets Articles

Aventis settles US drug price case for $190M

17 September 2007

Organon USa to distribute Sanofi-Aventis' Anzemet

12 December 2005

Amdipharm on track, targets L50M revenues

23 June 2003

NY claims of Rx overcharging could lead to industry-wide probe

24 February 2003

UK MCA proposes POM-to-P switches

16 August 2001

Anzemet Launched For PONV In USA

26 February 1998

1997: Another Good Year For New Chemical Entities

6 January 1998

HMR's Anzemet "Approvable" In USA

17 March 1997

HMR Files NDA for Dolasetron

22 April 1996

Hoechst Heads Into An Uncertain Future

25 March 1996

....And Marion Merrell Dow Updates On R&D Efforts

10 April 1995

Hoechst Offers $7 Billion For Marion Merrell Dow

6 March 1995

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS